
AbbVie Dividend Yield Holds at 3.4 Percent as New Drugs Drive 12.4 Percent Revenue Growth
AbbVie reports 12.4 percent revenue growth as new drugs offset Humira declines, supporting ABBV dividends. ...
Read more
AbbVie reports 12.4 percent revenue growth as new drugs offset Humira declines, supporting ABBV dividends. ...
Read more
Equinix targets at least 8 percent annual dividend growth through 2029, supported by steady AFFO ...
Read more
NextEra Energy maintains strong dividend growth of about 10% annually despite a modest yield. Capital ...
Read more
Broadcom’s AVGO dividends remain modest today, but dividend growth is among the strongest in the ...
Read more
ES dividends remain stable with a 4.6 percent forward yield despite regulatory pressure. Q1 GAAP ...
Read more
STAG dividends maintain a near 4 percent yield despite slowing growth The REIT’s shift from ...
Read more
Apple maintains a low 0.37 percent dividend yield despite record-high share prices Dividend growth remains ...
Read more
Eaton’s ETN dividends remain well supported by strong free cash flow and a consistent history ...
Read more
Target’s 3.5 percent dividend yield remains attractive but is supported by thin margins Shares are ...
Read more
JNJ dividends remain supported by strong free cash flow and a long record of annual ...
Read more